TABLE 2.
Subject no. | Sexc | Adverse reaction(s) | TNF-α (pg/ml)
|
IL-1β (pg/ml)
|
||
---|---|---|---|---|---|---|
Baseline | 3 h | Baseline | 3 h | |||
2 | F | None | UDa | UD | UDb | UD |
3 | F | None | UD | UD | UD | UD |
6 | M | None | UD | UD | UD | UD |
4 | M | None | UD | UD | UD | 1.2 |
9 | M | None | UD | UD | UD | 1.1 |
1 | M | None | UD | 52.9 | UD | 1.6 |
5 | F | Chills | UD | 40.6 | UD | 1.2 |
7 | F | Nausea and vomiting | UD | 161.1 | UD | 1.9 |
8 | F | Chills | UD | 26.2 | 2.2 | 3.2 |
11 | F | Chills | UD | 71.4 | UD | 1.2 |
10 | M | Chills and fever | UD | 53.2 | UD | 1.7 |
12 | M | Chills and headache | UD | 124.4 | 0 | 1.1 |
UD, undetectable TNF-α concentration (lower limit of detection, 1.6 pg/ml).
UD, undetectable IL-1β concentration (lower limit of detection, 0.7 pg/ml).
M, male; F, female.